与牛皮相比,结性脊髓炎中炎症性肠病的风险增加
Zhen He1, Yi-Nan Zhang1, James Cheng-Chung Wei2,3,4
1Department of Rheumatology and Immunology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Frontiers in immunology
|February 23, 2026
概括
与牛皮 (PSO) 和牛皮性关节炎 (PsA) 相比,性脊柱炎 (AS) 显著增加了炎症性肠病 (IBD) 的风险,包括克罗恩病和性结肠炎. 在这些疾病中,AS患者面临的IBD负担最高.
科学领域:
- 风湿病学和胃肠道学
- 免疫皮肤学和免疫学
- 流行病学和生物统计学
背景情况:
- 化脊柱炎 (AS) 和牛皮性关节炎 (PsA) 分享免疫失调路径.
- 在AS,PsA和牛皮 (PSO) 中发展炎症性肠病 (IBD) 亚型的比较风险尚未确定.
研究的目的:
- 量化和比较AS,PSO和PsA队列中IBD发展的风险梯度.
- 为了确定与每个疾病相关的IBD相对风险.
主要方法:
- 从2005-2023年使用电子健康记录的回顾性队列研究.
- 倾向性得分匹配 (PSM) 来控制混变量.
- 考克斯的比例危险模型和日志等级测试来评估IBD风险.
主要成果:
- 与PSO相比,AS的确定的IBD (HR=2.96),克罗恩病 (HR=3.38),性结肠炎 (HR=2.43) 和不确定的结肠炎 (HR=2.45) 的风险明显更高.
- 与普通人群相比,AS为确定的IBD (HR=4.22) 赋予了最高的独立风险,PSA (HR=1.52) 和PSO (HR=1.37).
- 亚氏硬化症的确切IBD风险比PSA高2.60倍.
结论:
- 结性脊柱炎是与IBD最强烈相关的表型.
- 与牛皮患者相比,AS患者患克罗恩病,性结肠炎和不确定的结肠炎的风险明显增加.
- 与牛皮关节炎或一般人群相比,AS携带的确定的IBD负担更大.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Chronic Bowel Disorders: Introduction
839
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
839
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
633
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
633
Drugs for Treatment of Ulcerative Colitis in IBD
565
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
565
Autoimmune Disorders
2.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.0K


